Corline Biomedical AB (STO:CLBIO)

Corline Biomedical AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 27, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	406	352	189	320	198	314
Market Cap Growth	68.67%	86.79%	-41.07%	61.60%	-36.85%	25.86%
Enterprise Value	385	347	181	303	169	271
Last Close Price	15.85	16.40	8.78	14.90	9.22	14.60
PE Ratio	-	-	-	-	85.08	-
PS Ratio	47.28	41.05	10.93	9.02	6.08	18.25
PB Ratio	4.33	3.76	2.17	3.43	2.10	3.40
P/TBV Ratio	4.33	3.76	2.17	3.43	2.10	3.40
P/FCF Ratio	-	-	-	424.69	-	-
P/OCF Ratio	-	-	-	361.41	-	-
EV/Sales Ratio	44.89	40.37	10.50	8.54	5.20	15.75
EV/EBITDA Ratio	-	-	-	-	71.03	-
EV/EBIT Ratio	-	-	-	-	72.74	-
EV/FCF Ratio	-21.73	-	-	402.14	-	-
Net Debt / Equity Ratio	-0.22	-0.22	-0.20	-0.18	-0.28	-0.45
Net Debt / EBITDA Ratio	1.40	1.40	1.31	8.09	-10.99	6.05
Net Debt / FCF Ratio	1.16	1.16	2.05	-22.56	3.97	8.37
Asset Turnover	0.09	0.09	0.18	0.35	0.32	0.22
Quick Ratio	4.74	4.74	2.59	3.28	4.82	4.71
Current Ratio	4.98	4.98	2.68	3.51	5.00	4.75
Return on Equity (ROE)	-16.29%	-16.29%	-25.74%	-1.93%	2.49%	-9.60%
Return on Assets (ROA)	-9.56%	-9.56%	-8.72%	-1.36%	1.43%	-5.40%
Return on Capital Employed (ROCE)	-15.80%	-15.80%	-15.60%	-2.40%	2.50%	-7.50%
Earnings Yield	-3.62%	-4.17%	-12.29%	-0.56%	1.18%	-2.21%
FCF Yield	-4.37%	-5.03%	-4.58%	0.24%	-3.33%	-1.59%
Buyback Yield / Dilution	-13.40%	-13.40%	-1.49%	2.19%	-7.50%	-22.58%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.